Full-Time
Vice President
Product
Posted on 9/13/2025
Omada Health
501-1,000 employees
Virtual care provider delivering chronic-condition management
Compensation Overview
$272k - $340k/yr
Remote in USA
Remote
Remote; USA-based. Remote-first culture indicates can work from home; no in-office requirement stated.
 Engineering Management (7) |
|---|
| , , , , , , |
- 15+ years of product management and design experience supporting technical solutions with a substantial part of this experience in a leadership role, preferably in a technology-driven health-focused environment
- Demonstrated history of successfully developing and executing product strategies and leading a product organization, ideally in the healthcare or related sectors.
- Analytical thinking and a strong understanding of using data to inform product decisions.
- Knowledge and validated use of agile software development practices including Scrum/Agile methodology and continuous integration and delivery (CI/CD) for delivering software applications and platforms
- Demonstrated fluency and track record in designing, developing, and launching AI-based products in a highly regulated industry setting
- Proven track record of ability to inspire and motivate teams, build trust, foster a collaborative culture while driving high performing teams
- Excellent communication and interpersonal skills, capable of effectively articulating complex concepts to a broad range of stakeholders.
- Exceptional problem-solving skills and the ability to address complex challenges.
- A collaborative and team-first spirit focused on team growth and a passion for healthcare mission and innovation.
- Lead a 25-person high-performing product management and design team and collaborate extremely well with the engineering, marketing, client delivery, and clinical teams
- Understand and address both client and member needs and desires, while balancing capacity and ROI of investments
- Develop and articulate a clear and compelling product vision, strategy, and roadmap aligned with the company's corporate strategy and market opportunities
- Build and execute against a product roadmap that drives innovation, user experience, technical leadership, and strategic impact
- Deeply understand market trends, member and client needs, competitive landscape, and emerging technologies to identify opportunities for product innovation and differentiation
- Foster a culture of innovation, collaboration, and accountability within the team while ensuring the work is ambitious, data-driven and relentlessly focused on health outcomes
- Manage the product management budget effectively, ensuring resources are allocated appropriately to achieve strategic goals
- Share the product vision both internally and externally, representing capabilities with key clients and external events
- Foster data-driven experimentation, encouraging the exploration of new ideas and technologies and rapid iteration of winning ideas
- Identify and mitigate potential risks related to product development and delivery, including but not limited to security, regulatory compliance, and privacy considerations.
- Champion a "customer value" first mindset, ensuring that Omada products are designed to meet customer needs effectively while delivering member outcomes consistently.
- Ensure the reliability and scalability of our systems so that our operations continue to deliver value while we experience high enrollment growth
- Evaluate the potential of new technologies and features for monetization.
- Maintain financial accountability for operational results relating to product experiences that impact overall financial performance of the company
- Extensive knowledge of the healthcare industry and digital health trends, with a proven ability to anticipate and capitalize on market shifts.
- Experience delivering technical solutions to large enterprise customers
- Experience with healthcare billing and reimbursement requirements and/or payment systems
Omada Health provides virtual-first, integrated care with clinically supported programs for chronic conditions. Its online programs use evidence-based medical protocols combined with behavior science, delivered with the help of health coaches and clinical specialists to help people achieve long-term health improvements. The company serves over 1,600 enterprise customers and partners with major employers, health plans, and health systems, delivering personalized interventions for diabetes prevention, weight management, diabetes, hypertension, musculoskeletal issues, and behavioral health. Its goal is to make sustained healthy behavior possible by offering accessible, scalable care that reduces healthcare costs and improves ROI for partners.
Company Size
501-1,000
Company Stage
IPO
Headquarters
San Francisco, California
Founded
2011
Simplify's Take
What believers are saying
- Revenue grew 42% year-over-year in Q1 2026, surpassing one million members.
- Partnerships with Optum Rx and Eli Lilly expand GLP-1 prescribing access.
- 90% customer retention and 50% member engagement after two years drive scale.
What critics are saying
- GLP-1 shortages from Eli Lilly and Optum Rx drive churn among 150,000 members.
- Noom captures obesity clients like Costco with superior GLP-1 app engagement.
- Wegovy and Zepbound approvals obsolete cholesterol platform in 6-12 months.
What makes Omada Health unique
- Omada integrates cholesterol management with weight, glucose, blood pressure, and GLP-1 on one platform.
- Compassionate intelligence model combines human coaching with AI for cardiometabolic care.
- Launched cholesterol care February 19, 2026, with Costco as first customer.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote first - Join Omada from anywhere in the US. No matter where you’re located, we budget for travel so your team can come together.
Flexible vacation - Invest in yourself and your loved ones with flexible time away and monthly wellness days.
Parental leave - We support all new parents with competitive leave policies and flexible schedules upon return.
Omada program - Join our best-in-class program to reach your health goals, and invite a loved one to join you too.
Meeting-free days - Every Wednesday afternoon, we observe company-wide focus time with nothing on the calendar.
Resources to thrive - Invest in inclusion with resource groups, equity training, and a cross-functional team dedicated to belonging.
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 0%DESCRIPTION (provided by applicant): Approximately 32% of Medicare spending is attributed to diabetic populations, and the prevalence of diabetes is growing at an alarming rate. Approximately 79 million Americans have prediabetes. The landmark 2002 Diabetes Prevention Program (DPP) demonstrated that lifestyle modification is a successful approach to preventing diabetes. The DPP lifestyle changes reduced the risk of developing diabetes in patients with prediabetes by 58% at 3 years following the intervention. The DPP involved a curriculum of 16 lessons delivered one-on-one over 6 months and a follow-up maintenance program over the remaining year. While the DPP lifestyle modification program was overwhelmingly successful, its wide-spread implementation necessitates the development of cost-effective delivery channels. While the NIH and UnitedHealth Group have invested in a pilot program to adapt the curriculum to a group format delivered at the YMCA, alternatives that are scalable and accessible are necessary tomake the DPP available across a broader segment of society. Omada Health is developing an interactive DPP curriculum from the recently released CDC DPP curriculum; this curriculum is designed to be delivered on a user-friendly web-based platform that Omada Health has built for virtual small groups. The goal of this proposal is to enhance the basic DPP curriculum with interactive and tailored components to motivate and engage users, increase participation, and improve health outcomes. Research into specificelements of online behavior interventions has demonstrated that interactive features, such as personalized email contact and bulletin board participation, may improve user outcomes. Upon completion of these specific aims, Omada Health will conduct large pilot studies and commercialize the web-based DPP curriculum and platform through strategic partnerships. Omada Health's online distribution model makes this diabetes prevention program ideal for rapid, nationwide expansion. Not only is this solution scalable, but it is more convenient and accessible for individuals with limited time and does not depend on access to a particular geographic location or vendor. Thus, Omada Health's interactive DPP is an ideal alternative to the pioneering YMCA-based DPP and has the potential to revolutionize the delivery of diabetes prevention programs. Omada Health has assembled an impressive team of collaborators to support and enhance their efforts, including: Martha Funnell, MS, a prominent diabetes educatory and past-chairof the National Diabetes Education Program; Anne Peters, MD, a renowned dialectologist and head of the USC Clinical Diabetes Program; Mark Berman, MD, an internal medicine physician with a focus on lifestyle medicine; Chip Heath, PhD, Professor of Organizational Behavior at Stanford University, an expert in behavior modification; and Willem Van Lancker, a Lead User Experience Designer at Google. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: Preventing diabetes in the estimated 79 million Americans with prediabetes is a public health priority. Lifestyle modification programs that focus on physica activity and healthy diet have been shown to be highly effective in preventing diabetes. The goal of this project is to develop interactive componentssuch as games, group response fields, quizzes, and videos to improve an online, virtual group diabetes prevention program to motivate users towards better health and to prevent diabetes.
Omada Health, a digital healthcare company focused on chronic condition management, went public in June 2025 and currently has an $800 million market capitalisation. The company's mobile app provides between-visit guidance for patients with conditions like diabetes, hypertension and obesity, offering access to health coaches, specialists and tracking tools. Omada has achieved 90% customer retention and 50% member engagement after two years. The company reports that GLP-1 users on its platform experience 28% more weight loss than those using medication alone, whilst members who discontinued GLP-1 but continued with Omada regained only 1% of body weight versus 11% for non-users. The company grew sales by 53% in 2025, with profit margins rising from negative 16% to 6% in the fourth quarter. The stock trades at three times sales.
Omada Health reported Q4 2025 revenue of $75.85 million, flat year-over-year but beating the consensus estimate of $73 million by 3.9%. The digital health company posted earnings per share of $0.13, compared to $0 in the year-ago quarter, significantly exceeding the $0.03 analyst estimate. The company's total membership reached 886,000, surpassing the analyst average estimate of 860,009. Services revenue came in at $71.65 million, beating the $64.53 million estimate, whilst hardware revenue of $4.2 million fell short of the $4.96 million projection. Omada Health shares have returned 0.1% over the past month. The stock currently holds a Zacks Rank 3, suggesting it could perform in line with the broader market near term.
Omada Health reports Q4 profit, offers new GLP-1 cash-pay option. The digital health provider reported a profitable fourth quarter with strong revenue and membership growth in 2025, and a new employer-focused cash-pay option for GLP-1s. Published: 06 Mar 2026 Omada Health, a digital health provider focused on chronic disease, announced its first profitable quarter and a new cash-pay option for GLP-1 medications on March 5. The company shared its fiscal year 2025 financial results, reporting full-year revenue of $260 million, up 53% from $169.8 million in 2024. Its revenue for the fourth quarter (Q4) of 2025 increased by 58%, from $47.9 million in Q4 2024 to $75.8 million in Q4 2025. Additionally, the company turned a profit in Q4 2025, reporting net income of $5.1 million, compared with a net loss of $8.2 million in Q4 2024. It reduced its year-over-year net losses, ending 2025 with a net loss of $12.7 million, down from $47 million in 2024. Omada Health, which went public in June 2025, ended the year with 886,000, up 55% year over year. The company noted that it is supporting 150,000 members on GLP-1s, compared with more than 50,000 at the end of 2024. Company leaders highlighted the adoption of GLP-1s as a critical driver of growth. During an earnings call, Omada CFO Steven Cook stated that the "broad industry focus on cardiometabolic conditions, deeper penetration of multi-condition customers, strong adoption of our GLP-1 programs and more effective enrollment campaigns" were the primary growth drivers for the company in 2025. The company is making further inroads into the GLP-1 market. In addition to its GLP-1 Enhanced Care Track, which offers members on GLP-1 medications personalized access to care teams, nutrition support and more, and GLP-1 virtual prescribing capability, Omada Health has launched GLP-1 Flex Care. The new offering will allow members to purchase their GLP-1 medications on a cash-pay basis. The members will also receive medication management, nutrition and activity counseling and discontinuation support through the new offering. The offering is targeted at the 55% of large employers that do not yet cover GLP-1s for obesity, said Sean Duffy, co-founder, CEO and director of Omada Health, during the earnings call. "...it gives these employers a structured model, where, yes, for your comments, they do pay Omada and would pay Omada more for the GLP-1 Flex Care offering because that includes clinical evaluation, prescribing lab ordering and Omada lifestyle and behavioral support while eligible employees can purchase the branded GLPs out of pocket through vetted cash pay channels, of course, with a focus on accessing the lowest available price," he said. In addition to its GLP-1 offerings, company leaders highlighted its commitment to addressing chronic disease via its cardiometabolic suite, which includes digital health programs for diabetes and hypertension, as well as its recently launched cholesterol management service. "Our ability to support obesity and weight health, diabetes, hypertension, cholesterol and MSK conditions, and GLP-1 care as 1 provider continues to be a key differentiator and the growth across our cardiometabolic suite reflects this," said Wei-Li Shao, president of Omada Health, in the earnings call. Anuja Vaidya has covered the healthcare industry since 2012. She currently covers the virtual healthcare landscape, including telehealth, remote patient monitoring and digital therapeutics. Editor's note: A previous version of this article mistakenly stated that Omada Health went public in May 2025. The article was updated on 3/6/2026.
Omada Health has launched GLP-1 Flex Care, a new offering that enables employers to support obesity care whilst limiting direct medication costs. The programme provides clinical evaluation, prescribing and medical oversight, whilst members purchase GLP-1 medications independently through cash-pay channels. The solution addresses growing employee demand for GLP-1s whilst helping employers manage costs. Members receive clinical oversight, including titration management, side-effect support and nutrition counselling, alongside Omada's virtual care and coaching throughout their treatment. Research shows Omada's GLP-1 care track achieves 67% medication persistence at one year, compared to 47–49% in comparable studies, with members achieving 18.4% average weight loss versus 11.9% in real-world evidence. Omada has supported over 150,000 members on GLP-1s. The programme will be available to employers later in 2026.